Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Brenner, EJ; Ungaro, RC; Gearry, RB; Kaplan, GG; Kissous-Hunt, M; Lewis, JD; Ng, SC; Rahier, JF; Reinisch, W; Ruemmele, FM; Steinwurz, F; Underwood, FE; Zhang, X; Colombel, JF; Kappelman, MD

Ungaro, RC (corresponding author), Icahn Sch Med Mt Sinai, Henry Janowitz Div Gastroenterol, 17 E 102nd St 5th Floor, New York, NY 10029 USA.; Brenner, EJ (corresponding author), Univ N Carolina, Dept Pediat Gastroenterol, 333 S Columbia St,247 MacNider Hall,CB 7229, Chapel Hill, NC 27599 USA.

GASTROENTEROLOGY, 2020; 159 (2): 481

Abstract

BACKGROUND AND AIMS: The impact of Coronavirus disease 2019 (COVID-19) on patients with inflammatory bowel disease (IBD) is unknown. We sought to char......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索